Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fimmu.2021.777524
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Repolarization of Tumor‐Associated Macrophages via Imidazoquinoline‐Linked Nanobodies
- (2021) Evangelia Bolli et al. Advanced Science
- Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
- (2021) Helena Van Damme et al. Journal for ImmunoTherapy of Cancer
- Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
- (2021) Ana Rita Pombo Antunes et al. NATURE NEUROSCIENCE
- Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
- (2020) Ana Rita Pombo Antunes et al. eLife
- The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
- (2020) Cyrillo G. Brahm et al. Cancers
- Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
- (2020) Mark P. Chao et al. Frontiers in Oncology
- Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
- (2020) Christina A. von Roemeling et al. Nature Communications
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
- (2020) Janik Puttemans et al. Cancers
- Glioblastoma Immune Landscape and the Potential of New Immunotherapies
- (2020) Thomas Daubon et al. Frontiers in Immunology
- Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
- (2020) Elodie Pothin et al. Pharmaceutics
- Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
- (2020) Jinyang Hu et al. Frontiers in Immunology
- Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
- (2019) Gregor Hutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
- (2019) Suchismita Mohanty et al. Cell Death & Disease
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
- (2019) Evangelia Bolli et al. JOURNAL OF CONTROLLED RELEASE
- Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours
- (2019) Pieterjan Debie et al. JOURNAL OF CONTROLLED RELEASE
- Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
- (2018) Amanda Sparkes et al. FASEB JOURNAL
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
- (2018) Lei Wu et al. OncoImmunology
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Simultaneous epitope and transcriptome measurement in single cells
- (2017) Marlon Stoeckius et al. NATURE METHODS
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
- (2017) Els Beirnaert et al. Frontiers in Immunology
- Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
- (2017) Feng Li et al. OncoImmunology
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging
- (2014) Sam Massa et al. BIOCONJUGATE CHEMISTRY
- Expression of Tumor-Associated Macrophage in Progression of Human Glioma
- (2014) Peng Ding et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models
- (2014) Cindy Leten et al. JOURNAL OF NEURO-ONCOLOGY
- Expression, purification and X-ray crystallographic analysis of theHelicobacter pyloriblood group antigen-binding adhesin BabA
- (2014) Suresh Subedi et al. Acta Crystallographica Section F-Structural Biology Communications
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
- (2013) M Lemaire et al. LEUKEMIA
- Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
- (2012) Tengfei Li et al. FASEB JOURNAL
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- (2012) D Kim et al. LEUKEMIA
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- (2012) B. Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
- (2012) Brian C. Baumann et al. Jove-Journal of Visualized Experiments
- Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
- (2010) Lea Olive Tchouate Gainkam et al. Contrast Media & Molecular Imaging
- In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT
- (2010) I. Vaneycken et al. JOURNAL OF NUCLEAR MEDICINE
- Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form
- (2010) Srinath Kasturirangan et al. NEUROBIOLOGY OF AGING
- A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines
- (2010) Daryl Rhys Jones et al. PLoS One
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More